Interview with the Innovators

Supported by BridgeBio

Transthyretin (TTR) amyloidosis: Disease Definition and Key Clinical Features

Ola Akinboboye, MD, MPH, MBA
Clinical Professor, Cardiology
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell & Medical Director
Laurelton Heart Specialists PC
Rosedale, NY
Ola Akinboboye, MD, MPH, MBA, Clinical Professor, Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health and Medical Director, Laurelton Heart Specialists PC (Rosedale, NY) describes the clinical manifestations of wild-type and hereditary or variant transthyretin amyloidosis (ATTR) and some common mutational drivers of pathogenic phenotypes.

Related Items

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to receive: